Author: gmp
-
Meet us at OncoPoint symposium
We are pleased to be invited at 11th edition of OncoPoint symposium organized by CRIG, where we had great discussions and could demonstrate our capabilities for manufacturing of advanced therapies. OncoPoint‘s aim is to provide a common interface to meet fellow cancer researchers from Ghent and discuss research, exchange information, and start collaborations. Cancer researchers from…
-
The novel Nobel I building welcomes the large new GMP unit ‘CellGENTherapies’ by 2026
On the UZ Gent campus, a new GMP unit is being built, covering no less than 1000 m2 and meeting the latest quality requirements. The new GMP unit will be fully operational by the end of 2026. With the new facilities, the University Hospital of Ghent (UZ Gent) continues to facilitate research into innovative applications…
-
Phase 1 clinical trial evaluating a neoantigen-targeted dendritic cell vaccine (Neo-mDC) in lung cancer patients
We are excited to share the publication by Ingels J., De Cock L.,et al.in Cell Reports Medicine, reporting the results of a phase 1 clinical trial evaluating a neoantigen-targeted dendritic cell vaccine (Neo-mDC) in lung cancer patients. CellGenTherapies had a pivotal role in advancing this highly personalized cancer vaccine to its first-in-human clinical trial. Neo-mDC…
-
mRNA-Based Therapeutics Summit
The team of the GMP unit CellGENTherapies will be present at the mRNA-Based Therapeutics Summit in Frankfurt Germany on 28th-30th of Jan 2025 – Europe’s Largest Industry-Led & Dedicated Gathering for mRNA Leaders 4th mRNA-Based Therapeutics Summit 2025 | Home With 40+ World-Class Speakers and assembling 200+ mRNA enthusiasts from across Europe, Asia and the…
-
The City of Ghent supports the GMP facility catalyzing scientific innovation
The City of Ghent supports future-oriented economic clusters, focusing on the present spearheads biotech & life sciences, cleantech, healthtech and digitech, in their further growth. For the further development of these ecosystems, both locally and internationally, the City of Ghent has established a spearhead fund of €4.9 million. The GMP facility ‘CellGENTherapies’ at University hospital…
-
EFRO, FWO and UZGent are funding new cleanroom facility for ATMP production at University Hospital Ghent
Headed by prof. Bart Vandekerckhove, in 2024 “CellGENTherapies”, the GMP unit of University Hospital of Ghent (UZ Gent) and the University of Ghent (Ugent), has received €4.6 million external funding from Europees Fonds voor Regionale Ontwikkeling (EFRO RNAvance), Fonds voor Innoveren en Ondernemen (FIO) and Fonds voor Wetenschappelijk Onderzoek (FWO-Hercules). This budget supplemented with an…